Kendall D A, Brown E, Nahorski S R
Eur J Pharmacol. 1985 Aug 7;114(1):41-52. doi: 10.1016/0014-2999(85)90518-7.
The characteristics of catecholamine-mediated breakdown of inositol phospholipids in rat cerebral cortex slices have been examined using a direct assay involving prelabeling with [3H]inositol and examining the production of labelled inositol phosphates in the presence of lithium. Noradrenaline produced a marked stimulation of inositol phosphate accumulation and this response could be potently and competitively antagonised by the alpha 1-adrenoceptor antagonist prazosin. The alpha 2-antagonist yohimbine was almost 1000-fold less potent at antagonising noradrenaline inositol phospholipid response. Noradrenaline and adrenaline were full agonists at alpha 1-adrenoceptors but phenylephrine and methoxamine were only partial agonists in their ability to stimulate inositol phospholipid metabolism. There was a significant correlation between the ability of a variety of agonists and antagonists to activate or inhibit [3H]inositol phosphate accumulation and their ability to displace the alpha 1-adrenoceptor selective ligand [3H]prazosin from specific binding sites when assays were performed on rat cerebral cortical slices under identical conditions. The similarity of EC50 values of agonists stimulating inositol phosphate accumulation and their IC50 values in [3H]prazosin binding experiments suggested a close relationship between receptor occupancy and alpha 1-mediated inositol phosphate accumulation. Further experiments were performed to examine this directly by inactivating alpha 1-adrenoceptors with the alkylating antagonist phenoxybenzamine. After washing out unbound antagonist, [3H]prazosin binding was reduced to a very similar proportion to that observed on the maximal noradrenaline-stimulated accumulation of [3H]inositol phosphates in the slices. The EC50 values for noradrenaline-stimulated inositol phosphate accumulation was unaltered and the affinity of [3H]prazosin for the remaining sites was equally unaffected. In rats treated 14 days previously with i.c.v. 6-hydroxydopamine (2 X 250 micrograms) there was a small increase in alpha 1-adrenoceptor binding sites but a parallel shift to the left in the noradrenaline [3H]inositol phosphate accumulation dose-response curve. On the other hand, the partial agonist phenylephrine induced a larger maximal response in denervated animals without a change in the EC50 values. When slices from 6-hydroxydopamine treated animals were preincubated with phenoxybenzamine, the loss in alpha 1-adrenoceptor binding sites was greater than the reduction in the maximal response to noradrenaline. This may indicate the development of a small receptor reserve after denervation.(ABSTRACT TRUNCATED AT 400 WORDS)
利用一种直接检测方法,研究了大鼠大脑皮层切片中儿茶酚胺介导的肌醇磷脂分解的特征。该方法包括用[3H]肌醇进行预标记,并在锂存在的情况下检测标记肌醇磷酸的生成。去甲肾上腺素显著刺激了肌醇磷酸的积累,这种反应可被α1肾上腺素能受体拮抗剂哌唑嗪有效且竞争性地拮抗。α2拮抗剂育亨宾在拮抗去甲肾上腺素对肌醇磷脂的反应方面效力几乎低1000倍。去甲肾上腺素和肾上腺素是α1肾上腺素能受体的完全激动剂,但苯肾上腺素和甲氧明在刺激肌醇磷脂代谢的能力方面只是部分激动剂。当在相同条件下对大鼠大脑皮层切片进行检测时,多种激动剂和拮抗剂激活或抑制[3H]肌醇磷酸积累的能力与其从特异性结合位点置换α1肾上腺素能受体选择性配体[3H]哌唑嗪的能力之间存在显著相关性。激动剂刺激肌醇磷酸积累的EC50值与其在[3H]哌唑嗪结合实验中的IC50值相似,这表明受体占据与α1介导的肌醇磷酸积累之间存在密切关系。通过用烷基化拮抗剂苯氧苄胺使α1肾上腺素能受体失活,进一步进行实验直接对此进行研究。洗去未结合的拮抗剂后,[3H]哌唑嗪结合减少的比例与在切片中去甲肾上腺素刺激的[3H]肌醇磷酸最大积累量中观察到的比例非常相似。去甲肾上腺素刺激肌醇磷酸积累的EC50值未改变,[3H]哌唑嗪对其余位点的亲和力同样未受影响。在用脑室内注射6-羟基多巴胺(2×250微克)处理14天的大鼠中,α1肾上腺素能受体结合位点略有增加,但去甲肾上腺素[3H]肌醇磷酸积累剂量-反应曲线向左平行移动。另一方面,部分激动剂苯肾上腺素在去神经动物中诱导出更大的最大反应,而EC50值没有变化。当用苯氧苄胺对6-羟基多巴胺处理动物的切片进行预孵育时,α1肾上腺素能受体结合位点的损失大于对去甲肾上腺素最大反应的降低。这可能表明去神经后出现了少量受体储备。(摘要截短至400字)